+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oral Proteins & Peptides Market Research Report by Drug Type (Calcitonin, Insulin, and Linaclotide), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 238 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968731
UP TO OFF until Dec 31st 2022
The Global Oral Proteins & Peptides Market size was estimated at USD 1,096.79 million in 2021, USD 1,240.45 million in 2022, and is projected to grow at a CAGR 13.27% to reach USD 2,317.04 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Oral Proteins & Peptides to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the market was studied across Calcitonin, Insulin, Linaclotide, Octreotide, and Plecanatide.
  • Based on Application, the market was studied across Bone Diseases, Diabetes, Gastric & Digestive Disorders, and Hormonal Disorders.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Oral Proteins & Peptides market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Proteins & Peptides Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Proteins & Peptides Market, including Allergan Plc., AstraZeneca PLC, Biocon Limited, Chiasma Inc., Generex Biotechnology Corp., Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Proxima Concepts Limited, Synergy Pharmaceuticals Inc., and Tarsa Therapeutics Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Oral Proteins & Peptides Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Proteins & Peptides Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Proteins & Peptides Market?
4. What is the competitive strategic window for opportunities in the Global Oral Proteins & Peptides Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Proteins & Peptides Market?
6. What is the market share of the leading vendors in the Global Oral Proteins & Peptides Market?
7. What modes and strategic moves are considered suitable for entering the Global Oral Proteins & Peptides Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of chronic diseases
5.1.1.2. Rise in patient preference for oral drugs
5.1.1.3. Growing demand for effective drugs and technology
5.1.2. Restraints
5.1.2.1. High manufacturing costs and low bioavailability
5.1.3. Opportunities
5.1.3.1. Rise in oral peptide and protein therapeutics applications
5.1.3.2. Increase in R&D by pharmaceutical companies
5.1.4. Challenges
5.1.4.1. Concerns related to unwanted enzymatic degradation and inherent structural complexities
5.2. Cumulative Impact of COVID-19
6. Oral Proteins & Peptides Market, by Drug Type
6.1. Introduction
6.2. Calcitonin
6.3. Insulin
6.4. Linaclotide
6.5. Octreotide
6.6. Plecanatide
7. Oral Proteins & Peptides Market, by Application
7.1. Introduction
7.2. Bone Diseases
7.3. Diabetes
7.4. Gastric & Digestive Disorders
7.5. Hormonal Disorders
8. Americas Oral Proteins & Peptides Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Oral Proteins & Peptides Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Oral Proteins & Peptides Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Allergan Plc.
12.2. AstraZeneca PLC
12.3. Biocon Limited
12.4. Chiasma Inc.
12.5. Generex Biotechnology Corp.
12.6. Novo Nordisk A/S
12.7. Oramed Pharmaceuticals Inc.
12.8. Proxima Concepts Limited
12.9. Synergy Pharmaceuticals Inc.
12.10. Tarsa Therapeutics Inc.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET DYNAMICS
FIGURE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 22. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 34. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2027
FIGURE 36. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 42. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2027
FIGURE 44. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 46. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2027
FIGURE 48. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. TAIWAN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2027
FIGURE 63. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 75. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ORAL PROTEINS & PEPTIDES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LINACLOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY OCTREOTIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PLECANATIDE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY BONE DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GASTRIC & DIGESTIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 56. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 59. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 60. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 61. BRAZIL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 62. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 64. CANADA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 65. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 67. MEXICO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 68. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 72. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 76. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 78. AUSTRALIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 81. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 82. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 84. INDIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 85. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 87. INDONESIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 88. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 90. JAPAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 91. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 93. MALAYSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 94. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 96. PHILIPPINES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 97. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 99. SINGAPORE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 100. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 102. SOUTH KOREA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 103. TAIWAN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. TAIWAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 105. TAIWAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 106. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 108. THAILAND ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 113. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 115. FRANCE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 118. GERMANY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 119. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 121. ITALY ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 122. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 124. NETHERLANDS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 125. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 127. QATAR ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 128. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 130. RUSSIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 131. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 133. SAUDI ARABIA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 134. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 136. SOUTH AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 137. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 139. SPAIN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 143. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 145. UNITED KINGDOM ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 147. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 148. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 149. GLOBAL ORAL PROTEINS & PEPTIDES MARKET RANKING
TABLE 150. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 151. GLOBAL ORAL PROTEINS & PEPTIDES MARKET MERGER & ACQUISITION
TABLE 152. GLOBAL ORAL PROTEINS & PEPTIDES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 153. GLOBAL ORAL PROTEINS & PEPTIDES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 154. GLOBAL ORAL PROTEINS & PEPTIDES MARKET INVESTMENT & FUNDING
TABLE 155. GLOBAL ORAL PROTEINS & PEPTIDES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 156. GLOBAL ORAL PROTEINS & PEPTIDES MARKET: LICENSE & PRICING

Companies Mentioned

  • Allergan Plc.
  • AstraZeneca PLC
  • Biocon Limited
  • Chiasma Inc.
  • Generex Biotechnology Corp.
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Proxima Concepts Limited
  • Synergy Pharmaceuticals Inc.
  • Tarsa Therapeutics Inc.

Methodology

Loading
LOADING...